Guest User

US Patent List on Cannabis. Copy and share!

a guest
Oct 6th, 2012
93
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
  1. The Cannabis Re-Education Center » united states government » us patent and trademark office
  2. File
  3. Size
  4. Last Modified
  5. Folder?? - 20110228.041047
  6. !--FEATURED PATENTS/FEATURED PATENTS - 20110221.122304
  7. 2304669_1942_Isolation_of_cannabidiol/2304669 1942 Isolation of cannabidiol - 20110217.005017
  8. 2354492_1944_Marihuana_active_compound/2354492 1944 Marihuana active compound - 20110217.005419
  9. 2419934_1947_Optically_active_tetrahydrodibenzopyrans_having_marihuana_activity_and_process_for_making_same/2419934 1947 Optically active tetrahydrodibenzopyrans having marihuana activity and process for .. - 20110217.010128
  10. 2419935_1947_Marihuana_active_compounds/2419935 1947 Marihuana active compounds - 20110217.010934
  11. 2419936_1947_Preparation_of_compounds_with_marihuana_activity/2419936 1947 Preparation of compounds with marihuana activity - 20110217.011517
  12. 2509386_1950_Dibenzopyran_marihuana-like_compounds/2509386 1950 Dibenzopyran marihuana-like compounds - 20110217.012129
  13. 2509387_1950_Dibenzopyran_marihuana-like_compounds/2509387 1950 Dibenzopyran marihuana-like compounds - 20110217.012513
  14. 3668224_1972_Process_of_producing_6a,_10a-trans-6a,7,8,10a-tetrahydrodibenzo_(b,d)-pyrans/3668224 1972 Process of producing 6a, 10a-trans-6a,7,8,10a-tetrahydrodibenzo (b,d)-pyrans - 20110217.013244
  15. 3728360_1973_Ester_derivatives_of_tetrahydrocannabinol/3728360 1973 Ester derivatives of tetrahydrocannabinol - 20110217.013646
  16. 3734930_1973_Direct_synthesis_of_(-)-trans-delta-9-tetrahydrocannabinol_from_olivetol_and_(+)-trans-delta-2-carene_oxide/3734930 1973 Direct synthesis of (-)-trans-delta-9-tetrahydrocannabinol from olivetol and (+)-tr.. - 20110217.005434
  17. 4025516_1977_Process_for_the_preparation_of_(-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans/4025516 1977 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.022419
  18. 4116979_1978_Process_for_the_preparation_of_(-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans/4116979 1978 Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-p.. - 20110217.030800
  19. 4126694_1978_Composition_and_method_for_treating_glaucoma/4126694 1978 Composition and method for treating glaucoma - 20110217.031302
  20. 4126695_1978_Anti-glaucoma_composition_and_method/4126695 1978 Anti-glaucoma composition and method - 20110217.031624
  21. 4179517_1979_Novel_tetrahydrocannabinol_type_compounds/4179517 1979 Novel tetrahydrocannabinol type compounds - 20110217.032121
  22. 4189491_1980_Tetrahydrocannabinol_in_a_method_of_treating_glaucoma/4189491 1980 Tetrahydrocannabinol in a method of treating glaucoma - 20110217.032351
  23. 4195078_1980_Nabilone_granulation/4195078 1980 Nabilone granulation - 20110219.131638
  24. 4279824_1981_Method_and_apparatus_for_processing_herbaceous_plant_materials_including_the_plant_cannabis/4279824 1981 Method and apparatus for processing herbaceous plant materials including the plant .. - 20110221.005824
  25. 4315862_1982_Process_for_preparing_cannabichromene/4315862 1982 Process for preparing cannabichromene - 20110219.132528
  26. 4327028_1982_Composition_of_matter/4327028 1982 Composition of matter - 20110219.132854
  27. 4464378_1984_Method_of_administering_narcotic_antagonists_and_analgesics/4464378 1984 Method of administering narcotic antagonists and analgesics - 20110219.134318
  28. 4476140_1984_Composition_and_method_for_treatment_of_glaucoma/4476140 1984 Composition and method for treatment of glaucoma - 20110219.133925
  29. 4758597_1988_Carenadiol_and_derivatives/4758597 1988 Carenadiol and derivatives - 20110220.235422
  30. 4837228_1989_Antiinflammatory_and_antimicrobial_compounds_and_compositions/4837228 1989 Antiinflammatory and antimicrobial compounds and compositions - 20110219.135422
  31. 4847290_1989_Delta_1-thc-7-oic_acid_and_analgesic_and_anti-inflammatory_agents/4847290 1989 Delta 1-thc-7-oic acid and analgesic and anti-inflammatory agents - 20110219.140914
  32. 4876276_1989_(3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols/4876276 1989 (3s-4s)-7-hydroxy-delta-6-tetrahydrocannabinols - 20110219.141600
  33. 4933363_1990_Method_for_effecting_systemic_delivery_of_delta-9-tetrahydrocannabinol/4933363 1990 Method for effecting systemic delivery of delta-9-tetrahydrocannabinol - 20110219.144031
  34. 5227537_1993_Method_for_the_production_of_6,12-dihydro-6-hydroxy-cannabidiol_and_the_use_thereof_for_the_production_of_trans-delta-9-tetrahydrocannabinol/5227537 1993 Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof.. - 20110221.005135
  35. 5237057_1993_Tetrahydrocannabinol_derivatives_and_protein_and_polypeptide_tetrahydrocannabinol_derivative_conjugates_and_labels/5237057 1993 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.144538
  36. 5292899_1994_Synthesis_of_11-nor-delta-9-tetrahydrocannabinol-9-carboxylic_acid_glucuronide/5292899 1994 Synthesis of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid glucuronide - 20110219.145249
  37. 5302703_1994_Tetrahydrocannabinol_derivatives_and_protein_and_polypeptide_tetrahydrocannabinol_derivative_conjugates_and_labels/5302703 1994 Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol d.. - 20110219.145809
  38. 5338753_1994_(3r,4r)-delta-6-tetrahydrocannabinol-7-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/5338753 1994 (3r,4r)-delta-6-tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents .. - 20110219.150617
  39. 5342971_1994_Process_for_the_preparation_of_dibenzo[b,d]pyrans/5342971 1994 Process for the preparation of dibenzo[b,d]pyrans - 20110219.150655
  40. 5389375_1995_Stable_suppository_formulations_effecting_bioavailability_of_delta-9-thc/5389375 1995 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151015
  41. 5440052_1995_Compositions_useful_as_a_cannabinoid_receptor_probe/5440052 1995 Compositions useful as a cannabinoid receptor probe - 20110219.151453
  42. 5508037_1996_Stable_suppository_formulations_effecting_bioavailability_of_delta-9-thc/5508037 1996 Stable suppository formulations effecting bioavailability of delta-9-thc - 20110219.151931
  43. 5532237_1996_Indole_derivatives_with_affinity_for_the_cannabinoid_receptor/5532237 1996 Indole derivatives with affinity for the cannabinoid receptor - 20110219.152606
  44. 5538993_1996_Certain_tetrahydrocannabinol-7-oic_acid_derivatives/5538993 1996 Certain tetrahydrocannabinol-7-oic acid derivatives - 20110219.152901
  45. 5596106_1997_Cannabinoid_receptor_antagonists/5596106 1997 Cannabinoid receptor antagonists - 20110219.153207
  46. 5605906_1997_Cannabinoid_receptor_agonists/5605906 1997 Cannabinoid receptor agonists - 20110219.153325
  47. 5605928_1997_Antiemetic_compositions/5605928 1997 Antiemetic compositions - 20110219.153523
  48. 5631297_1997_Anandamides_useful_for_the_treatment_of_intraocular_hypertension.../5631297 1997 Anandamides useful for the treatment of intraocular hypertension... - 20110219.160906
  49. 5635530_1997_(3s,4s)-delta-6-tetrahydrocannabinol-7-oic_acids_and_derivatives_thereof,_processors_for_their_preparation_and_pharmaceutical_compositions_containing_them/5635530 1997 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processor.. - 20110219.154139
  50. 5688825_1997_Anandamide_amidase_inhibitors_as_analgesic_agents/5688825 1997 Anandamide amidase inhibitors as analgesic agents - 20110219.161202
  51. 5716638_1998_Composition_for_applying_active_substances_to_or_through_the_skin/5716638 1998 Composition for applying active substances to or through the skin - 20110219.161548
  52. 5747524_1998_Cannabinoid_receptor_antagonists/5747524 1998 Cannabinoid receptor antagonists - 20110219.161846
  53. 5804592_1998_Method_for_improving_disturbed_behavior_and_elevating_mood_in_humans/5804592 1998 Method for improving disturbed behavior and elevating mood in humans - 20110219.162419
  54. 5847128_1998_Water_soluble_derivatives_of_cannabinoids/5847128 1998 Water soluble derivatives of cannabinoids - 20110219.162859
  55. 5872148_1999_Compositions_useful_as_a_cannabinoid_receptor_probe/5872148 1999 Compositions useful as a cannabinoid receptor probe - 20110219.163222
  56. 5874459_1999_Anandamide_amidase_inhibitors_as_analgesic_agents/5874459 1999 Anandamide amidase inhibitors as analgesic agents - 20110219.163805
  57. 5925768_1999_pyrazolecarboxamide_derivatives_having_cannabinoid_receptor_affinity/5925768 1999 pyrazolecarboxamide derivatives having cannabinoid receptor affinity - 20110219.164326
  58. 5932610_1999_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/5932610 1999 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110219.164744
  59. 5939429_1999_Cardiovascular_uses_of_cannabinoid_compounds/5939429 1999 Cardiovascular uses of cannabinoid compounds - 20110219.164958
  60. 5948777_1999_Cannabinoid_receptor_agonists/5948777 1999 Cannabinoid receptor agonists - 20110219.165232
  61. 5977180_1999_Anandamide_analog_compositions_and_method_of_treating_intraocular_hypertension_using_same/5977180 1999 Anandamide analog compositions and method of treating intraocular hypertension usin.. - 20110219.165507
  62. 5990170_1999_Therapeutic_use_of_mono_and_bicarboxylic_acid_amides_active_at_the_peripheral_cannabinoid_receptor/5990170 1999 Therapeutic use of mono and bicarboxylic acid amides active at the peripheral canna.. - 20110219.165901
  63. 6008383_1999_Method_of_preparing_delta-9-tetrahydrocannabinol_esters/6008383 1999 Method of preparing delta-9-tetrahydrocannabinol esters - 20110219.170127
  64. 6013648_2000_Cb2_receptor_agonist_compounds/6013648 2000 Cb2 receptor agonist compounds - 20110219.170359
  65. 6017919_2000_Compounds_and_pharmaceutical_use_thereof/6017919 2000 Compounds and pharmaceutical use thereof - 20110219.232239
  66. 6096740_2000_Dexanabinol_derivatives_and_their_use_as_neuroprotective_pharmaceutical_compositions/6096740 2000 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions - 20110219.232844
  67. 6100259_2000_Cannabinoid_receptor_modulators/6100259 2000 Cannabinoid receptor modulators - 20110219.233213
  68. 6113940_2000_Cannabinoid_patch_and_method_for_cannabis_transdermal_delivery/6113940 2000 Cannabinoid patch and method for cannabis transdermal delivery - 20110219.233850
  69. 6132762_2000_Transcutaneous_application_of_marijuana/6132762 2000 Transcutaneous application of marijuana - 20110219.234036
  70. 6162829_2000_(3r,4r)-delta-8-tetrahydrocannabinol-11-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/6162829 2000 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110219.234311
  71. 6166066_2000_Cannabinoids_selective_for_the_cb2_receptor/6166066 2000 Cannabinoids selective for the cb2 receptor - 20110219.234631
  72. 6274635_2001_Alkylated_resorcinol_derivatives_for_the_treatment_of_immune_diseases/6274635 2001 Alkylated resorcinol derivatives for the treatment of immune diseases - 20110219.235354
  73. 6284788_2001_Use_of_known_agonists_of_the_central_cannabinoid_receptor_cb1/6284788 2001 Use of known agonists of the central cannabinoid receptor cb1 - 20110219.235654
  74. 6328992_2001_Cannabinoid_patch_and_method_for_cannabis_transdermal_delivery/6328992 2001 Cannabinoid patch and method for cannabis transdermal delivery - 20110220.000814
  75. 6331560_2001_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/6331560 2001 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.002503
  76. 6344474_2002_Use_of_central_cannabinoid_receptor_antagonists_for_regulating_appetence/6344474 2002 Use of central cannabinoid receptor antagonists for regulating appetence - 20110220.002717
  77. 6355650_2002_(3r,4r)-delta-8-tetrahydrocannabinol-11-oic_acids_useful_as_antiinflammatory_agents_and_analgesics/6355650 2002 (3r,4r)-delta-8-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents.. - 20110220.002953
  78. 6380175_2002_Method_for_enhancement_of_delivery_of_thc_by_the_administration_of_its_prodrugs_via_the_nasal_route/6380175 2002 Method for enhancement of delivery of thc by the administration of its prodrugs via.. - 20110220.003309
  79. 6383513_2002_Compositions_comprising_cannabinoids/6383513 2002 Compositions comprising cannabinoids - 20110220.003536
  80. 6391909_2002_Anandamide_inhibitors_as_analgesic_agents/6391909 2002 Anandamide inhibitors as analgesic agents - 20110220.003752
  81. 6448288_2002_Cannabinoid_drugs/6448288 2002 Cannabinoid drugs - 20110220.004111
  82. 6509005_2003_delta-9_tetrahydrocannabinol_(delta-9_thc)_solution_metered_dose_inhaler/6509005 2003 delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhaler - 20110220.010440
  83. 6509367_2003_Pyrazole_cannabinoid_agonist_and_antagonists/6509367 2003 Pyrazole cannabinoid agonist and antagonists - 20110220.010824
  84. 6545041_2003_Tumor_necrosis_factor_alpha_(tnf-alpha)_inhibiting_pharmaceuticals/6545041 2003 Tumor necrosis factor alpha (tnf-alpha) inhibiting pharmaceuticals - 20110220.011159
  85. 6563009_2003_Vasodilator_cannabinoid_analogs/6563009 2003 Vasodilator cannabinoid analogs - 20110220.011723
  86. 6566560_2003_Resorcinolic_compounds/6566560 2003 Resorcinolic compounds - 20110220.012340
  87. 6579900_2003_Anandamide_amidase_inhibitors_as_analgesic_agents/6579900 2003 Anandamide amidase inhibitors as analgesic agents - 20110220.013014
  88. 6610737_2003_Non_psychotropic_cannabinoids/6610737 2003 Non psychotropic cannabinoids - 20110220.013607
  89. 6630507_2003_Cannabinoids_as_antioxidants_and_neuroprotectants/6630507 2003 Cannabinoids as antioxidants and neuroprotectants - 20110217.040403
  90. 6642258_2003_Use_of_central_cannabinoid_receptor_antagonist_for_preparing_medicines/6642258 2003 Use of central cannabinoid receptor antagonist for preparing medicines - 20110220.141047
  91. 6653304_2003_Cannabinoid_receptor_modulators,_their_processes_of_preparation,_and_use_of_cannabinoid_receptor_modulators_for_treating_respiratory_and_non-respiratory_diseases/6653304 2003 Cannabinoid receptor modulators, their processes of preparation, and use of cannabi.. - 20110220.141700
  92. 6703418_2004_Appetite_stimulation_and_induction_of_weight_gain_in_patients_suffering_from_symptomatic_hiv_infection/6703418 2004 Appetite stimulation and induction of weight gain in patients suffering from sympto.. - 20110220.141926
  93. 6713048_2004_Delta-9_tetrahydrocannabinol_(delta-9_thc)_solution_metered_dose_inhalers_and_methods_of_use/6713048 2004 Delta-9 tetrahydrocannabinol (delta-9 thc) solution metered dose inhalers and metho.. - 20110220.142152
  94. 6747058_2004_Stable_composition_for_inhalation_therapy_comprising_delta-9-tetrahydrocannabinol_and_semiaqueous_solvent_therefor/6747058 2004 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol a.. - 20110220.142350
  95. 6825209_2004_Compounds_having_unique_cb1_receptor_binding_selectivity_and_methods_for_their_production_and_use/6825209 2004 Compounds having unique cb1 receptor binding selectivity and methods for their prod.. - 20110220.142627
  96. 6864291_2005_Agonists_specific_for_the_peripheral_cannabinoid_receptor/6864291 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.142827
  97. 6900236_2005_Cannabimimetic_indole_derivatives/6900236 2005 Cannabimimetic indole derivatives - 20110220.143112
  98. 6903137_2005_Agonists_specific_for_the_peripheral_cannabinoid_receptor/6903137 2005 Agonists specific for the peripheral cannabinoid receptor - 20110220.144738
  99. 6930122_2005_Use_of_central_cannabinoid_receptor_antagonist_for_preparing_medicines_designed_to_facilitate_smoking_cessation/6930122 2005 Use of central cannabinoid receptor antagonist for preparing medicines designed to .. - 20110220.225951
  100. 6939977_2005_Analgesic_and_immunomodulatory_cannabinoids/6939977 2005 Analgesic and immunomodulatory cannabinoids - 20110220.230157
  101. 6943266_2005_Bicyclic_cannabinoid_agonists_for_the_cannabinoid_receptor/6943266 2005 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110220.230355
  102. 6949582_2005_Method_of_relieving_analgesia_and_reducing_inflamation_using_a_cannabinoid_delivery_topical_liniment/6949582 2005 Method of relieving analgesia and reducing inflamation using a cannabinoid delivery.. - 20110220.230551
  103. 6974568_2005_Treatment_for_cough/6974568 2005 Treatment for cough - 20110220.231124
  104. 6995187_2006_Peripheral_cannabinoid_receptor_(cb2)_selective_ligands/6995187 2006 Peripheral cannabinoid receptor (cb2) selective ligands - 20110220.231316
  105. 7049329_2006_Amines_that_inhibit_a_mammalian_anandamide_transporter,_and_methods_of_use_thereof/7049329 2006 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof - 20110220.231649
  106. 7057076_2006_Bicyclic_and_tricyclic_cannabinoids/7057076 2006 Bicyclic and tricyclic cannabinoids - 20110220.231942
  107. 7067539_2006_Cannabinoid_receptor_ligands/7067539 2006 Cannabinoid receptor ligands - 20110220.232124
  108. 7071213_2006_Cannabinoid_receptor_ligands/7071213 2006 Cannabinoid receptor ligands - 20110220.232329
  109. 7088914_2006_Device,_method_and_resistive_element_for_vaporizing_a_medicament/7088914 2006 Device, method and resistive element for vaporizing a medicament - 20110220.232627
  110. 7105685_2006_Cannabinol_derivatives/7105685 2006 Cannabinol derivatives - 20110220.232801
  111. 7109245_2006_Vasoconstrictor_cannabinoid_analogs/7109245 2006 Vasoconstrictor cannabinoid analogs - 20110220.233007
  112. 7119108_2006_Pyrazole_derivatives_as_cannabinoid_receptor_antagonists/7119108 2006 Pyrazole derivatives as cannabinoid receptor antagonists - 20110220.233254
  113. 7129239_2006_Purine_compounds_and_uses_thereof/7129239 2006 Purine compounds and uses thereof - 20110220.233510
  114. 7141669_2006_Cannabiniod_receptor_ligands_and_uses_thereof/7141669 2006 Cannabiniod receptor ligands and uses thereof - 20110220.233811
  115. 7145012_2006_Cannabinoid_receptor_ligands_and_uses_thereof/7145012 2006 Cannabinoid receptor ligands and uses thereof - 20110220.234023
  116. 7161016_2007_Cannabimimetic_lipid_amides_as_useful_medications/7161016 2007 Cannabimimetic lipid amides as useful medications - 20110220.234200
  117. 7169942_2007_Cannabinoid_derivatives,_methods_of_making,_and_use_thereof/7169942 2007 Cannabinoid derivatives, methods of making, and use thereof - 20110220.234343
  118. 7173027_2007_Receptor_selective_cannabimimetic_aminoalkylindoles/7173027 2007 Receptor selective cannabimimetic aminoalkylindoles - 20110220.234621
  119. 7176210_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7176210 2007 Cannabinoid receptor ligands and uses thereof - 20110220.234841
  120. 7179800_2007_Cannabinoids/7179800 2007 Cannabinoids - 20110220.235606
  121. 7183313_2007_Keto_cannabinoids_with_therapeutic_indications/7183313 2007 Keto cannabinoids with therapeutic indications - 20110220.235821
  122. 7217732_2007_Cannabinoid_receptor_agonists/7217732 2007 Cannabinoid receptor agonists - 20110221.000020
  123. 7220743_2007_Heterocyclic_cb1_receptor_antagonists/7220743 2007 Heterocyclic cb1 receptor antagonists - 20110221.000208
  124. 7229999_2007_Pyridine-3-carboxamide_derivatives_as_cb1_inverse_agonists/7229999 2007 Pyridine-3-carboxamide derivatives as cb1 inverse agonists - 20110221.000408
  125. 7232823_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7232823 2007 Cannabinoid receptor ligands and uses thereof - 20110221.000602
  126. 7235584_2007_Non_psychotropic_cannabinoids/7235584 2007 Non psychotropic cannabinoids - 20110221.000739
  127. 7241799_2007_Cannabimimetic_indole_derivatives/7241799 2007 Cannabimimetic indole derivatives - 20110221.000920
  128. 7247628_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7247628 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001058
  129. 7268133_2007_Cannabinoid_receptor_ligands_and_uses_thereof/7268133 2007 Cannabinoid receptor ligands and uses thereof - 20110221.001308
  130. 7276516_2007_Cb1_antagonist_compounds/7276516 2007 Cb1 antagonist compounds - 20110221.002759
  131. 7276613_2007_Retro-anandamides,_high_affinity_and_stability_cannabinoid_receptor_ligands/7276613 2007 Retro-anandamides, high affinity and stability cannabinoid receptor ligands - 20110221.002935
  132. 7285683_2007_Bicyclic_and_tricyclic_cannabinoids/7285683 2007 Bicyclic and tricyclic cannabinoids - 20110221.003404
  133. 7285687_2007_Cannabinoids/7285687 2007 Cannabinoids - 20110221.003830
  134. 7294644_2007_Cb_1_receptor_inverse_agonists/7294644 2007 Cb 1 receptor inverse agonists - 20110221.004028
  135. 7321047_2008_Separation_of_tetrahydrocannabinols/7321047 2008 Separation of tetrahydrocannabinols - 20110221.004243
  136. 7323576_2008_Synthetic_route_to_dronabinol/7323576 2008 Synthetic route to dronabinol - 20110221.004441
  137. 7329651_2008_Cannabimimetic_ligands/7329651 2008 Cannabimimetic ligands - 20110221.004633
  138. 7329658_2008_Cannabinoid_receptor_ligands_and_uses_thereof/7329658 2008 Cannabinoid receptor ligands and uses thereof - 20110221.004825
  139. 7335688_2008_Bicyclic_cannabinoid_agonists_for_the_cannabinoid_receptor/7335688 2008 Bicyclic cannabinoid agonists for the cannabinoid receptor - 20110221.005006
  140. 7344736_2008_Extraction_of_pharmaceutically_active_components_from_plant_materials/7344736 2008 Extraction of pharmaceutically active components from plant materials - 20110221.005455
  141. 7354929_2008_Cannabinoid_receptor_ligands_and_uses_thereof/7354929 2008 Cannabinoid receptor ligands and uses thereof - 20110221.010029
  142. 7358245_2008_Treatment_of_gastroesophageal_reflux_disease/7358245 2008 Treatment of gastroesophageal reflux disease - 20110221.010322
  143. 7393842_2008_Pyrazole_analogs_acting_on_cannabinoid_receptors/7393842 2008 Pyrazole analogs acting on cannabinoid receptors - 20110221.010732
  144. 7399872_2008_Conversion_of_cbd_to_delta-8-thc_and_delta-9-thc/7399872 2008 Conversion of cbd to delta-8-thc and delta-9-thc - 20110221.011142
  145. 7402686_2008_Cannabinoid_crystalline_derivatives_and_process_of_cannabinoid_purification/7402686 2008 Cannabinoid crystalline derivatives and process of cannabinoid purification - 20110221.011644
  146. 7592328_2009_Natural_cyclodextrin_complexes/7592328 2009 Natural cyclodextrin complexes - 20110221.011900
  147. 7592468_2009_Production_of_delta-9_tetrahydrocannabinol/7592468 2009 Production of delta-9 tetrahydrocannabinol - 20110221.012444
  148. 7648696_2010_Composition_for_inhalation_comprising_delta-9-tetrahydrocannabinol_in_a_semiaqueous_solvent/7648696 2010 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous.. - 20110221.012955
  149. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 0KB 20110217.040441
  150. an_incomplete_list_of_cannabis-related_patents.txtan incomplete list of cannabis-related patents.txt 59KB 20110217.002348
RAW Paste Data